Open Access

Prioritization of candidate metabolites for postmenopausal osteoporosis using multi-omics composite network

  • Authors:
    • Chi Zhang
    • Yan Wang
    • Chun-Lei Zhang
    • Hua-Rong Wu
  • View Affiliations

  • Published online on: February 26, 2019     https://doi.org/10.3892/etm.2019.7310
  • Pages: 3155-3161
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Risk metabolites of postmenopausal osteoporosis (PO) were explored to offer a theoretical basis for future therapy. The data E-GEOD-7429 were downloaded from ArrayExpress database. In total 20 samples deprived from postmenopausal women having low or high bone mineral density (BMD) were covered in this expression profile. After screening of diffe- rentially expressed genes (DEGs), gene-gene network was constructed taking the intersection between the DEGs and genes in the seed protein-protein interaction network. Then, the other five networks were established, including metabolite, phenotype, gene-metabolite, phenotype-gene, and phenotype-metabolite networks. Next, these 6 networks were integrated into one weighted multi-omics network to further identify the candidate metabolites using random walk with restart based on the PO-related seed genes, seed metabolites and phenotype. Using the score among nodes of the weighted composite network, the top 50 metabolites, and the top 100 co-expressed genes interacting with the top 50 metabolites were detected. A set of 601 DEGs between low BMD and high BMD samples were selected. Significantly, the top 5 metabolites were respectively glucosylgalactosyl hydroxylysine, all-trans-5,6-epoxyretinoic acid, tretinoin, colecalciferol, and rocaltrol. Moreover, 3 metabolites (estraderm, triphosadenine, and tretinoin) had a degree >50 in the co-expression network. Tretinoin was the member of the top 5 metabolites, and estraderm was a metabolite with the seventh interaction score. A series of metabolites, tretinoin and estraderm might be closely associa- ted with the onset and progression of PO.
View Figures
View References

Related Articles

Journal Cover

April-2019
Volume 17 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang C, Wang Y, Zhang C and Wu H: Prioritization of candidate metabolites for postmenopausal osteoporosis using multi-omics composite network. Exp Ther Med 17: 3155-3161, 2019
APA
Zhang, C., Wang, Y., Zhang, C., & Wu, H. (2019). Prioritization of candidate metabolites for postmenopausal osteoporosis using multi-omics composite network. Experimental and Therapeutic Medicine, 17, 3155-3161. https://doi.org/10.3892/etm.2019.7310
MLA
Zhang, C., Wang, Y., Zhang, C., Wu, H."Prioritization of candidate metabolites for postmenopausal osteoporosis using multi-omics composite network". Experimental and Therapeutic Medicine 17.4 (2019): 3155-3161.
Chicago
Zhang, C., Wang, Y., Zhang, C., Wu, H."Prioritization of candidate metabolites for postmenopausal osteoporosis using multi-omics composite network". Experimental and Therapeutic Medicine 17, no. 4 (2019): 3155-3161. https://doi.org/10.3892/etm.2019.7310